When I saw slide 22 on the ferret study suggesting that EDP-235 prevented transmission I thought that was a pretty big deal. In that the trajectory was upwards before and there is a high expectation of a Phase 3 trial this year (against the China backdrop and expected continuation of covid) I decided to add a bit more.
And it seems others felt the same way. Per Finviz ENTA is up over 7% in the past week and +21% in the past month. I am keen also on the fact that they are working on a new additional Covid asset.
News 
Market Data 
Discover 
